Alzheimer’s disease (AD) is currently an incurable aging-related neurodegenerative disorder. Recent studies give support to the hypotheses that AD should be considered as a metabolic disease. The present study aimed to explore the relationship between hippocampal neuropathological amyloid-β (Aβ) plaque formation and obesity at an early presymptomatic disease stage (3 months of age). For this purpose, we used APPswe/PS1dE9 (APP/PS1) transgenic mice, fed with a high-fat diet (HFD) in order to investigate the potential molecular mechanisms involved in both disorders. The results showed that the hippocampus from APP/PS1 mice fed with a HFD had an early significant decrease in Aβ signaling pathway specifically in the insulin degrading enzyme protein levels, an enzyme involved in (Aβ) metabolism, and α-secretase. These changes were accompanied by a significant increase in the occurrence of plaques in the hippocampus of these mice. Furthermore, APP/PS1 mice showed a significant hippocampal decrease in PGC-1α levels, a cofactor involved in mitochondrial biogenesis. However, HFD does not provoke changes in neither insulin receptors gene expression nor enzymes involved in the signaling pathway. Moreover, there are no changes in any enzymes (kinases) involved in tau phosphorylation, such as CDK5, and neither in brain oxidative stress production. These results suggest that early changes in brains of APP/PS1 mice fed with a HFD are mediated by an increase in Aβ1 ‒ 42, which induces a decrease in PKA levels and alterations in the p-CREB/ NMDA2B /PGC1-α pathway, favoring early AD neuropathology in mice.
VishalS, SourabhA, HarkiratS (2011) Alois Alzheimer (1864-1915) and the Alzheimer syndrome. J Med Biogr19, 32–33.
2.
AlzheimerA, StelzmannRA, SchnitzleinHN, MurtaghFR (1995) An English translation of Alzheimer’s 1907 paper, “Uber eine eigenartige Erkrankung der Hirnrinde”. Clin Anat8, 429–431.
3.
WilsonRS, SegawaE, BoylePA, AnagnosSE, HizelLP, BennettDA (2012) The natural history of cognitive decline in Alzheimer’s disease. Psychol Aging27, 1008–1017.
4.
BarkerWW, LuisCA, KashubaA, LuisM, HarwoodDG, LoewensteinD (2002) Relative frequencies of Alzheimer’s disease, Lewy body, vascular and frontotemporal dementia, and hippocampal sclerosis in the State of Florida Brain Bank. Alzheimer Dis Assoc Disord16, 203–212.
5.
Alzheimer’s Association (2015) Alzheimer’s disease facts and figures. Alzheimers Dement11, 332–384.
6.
HardyJA, AllsopD (1991) Amyloid deposition as the central event in the aetiology of Alzheimer’s disease. Trends Pharmacol Sci12, 383–388.
HardyJA, SelkoeDJ (2002) The amyloid hypothesis of Alzheimer’s disease: Progress and problems on the road to therapeutics. Science297, 353–356.
9.
WalshDM, SelkoeDJ (2007) A beta oligomers—a decade of discovery. J Neurochem101, 1172–1184.
10.
SchneiderLS, MangialascheF, AndreasenN, FeldmanH, GiacobiniE, JonesR, MantuaV, MecocciP, PaniL, WinbladB, KivipeltoM (2014) Clinical trials and late-stage drug development for Alzheimer’s disease: An appraisal from 1984 to 2014. J Intern Med275, 251–283.
BondaDJ, WangX, LeeHG, SmithMA, PerryG, ZhuX (2014) Neuronal failure in Alzheimer’s disease: A view through the oxidative stress looking-glass. Neurosci Bull30, 243–252.
13.
SwerdlowRH (2012) Mitochondria and cell bioenergetics: Increasingly recognized components and a possible etiologic cause of Alzheimer’s disease. Antioxid Redox Signal16, 1434–1455.
SwerdlowRH, KhanSM (2015) A “mitochondrial cascade hypothesis” for sporadic Alzheimer’s disease. Med Hypotheses63, 8–20.
16.
DemetriusLA, DriverJ (2013) Alzheimer’s as a metabolic disease. Biogerontology14, 641–649.
17.
DemetriusLA, DriverJ (2015) Preventing Alzheimer’s disease by means of natural selection. J R Soc Interfac12, 20140919.
18.
ArnoldSE, LuckiI, BrookshireBR, CarlsonGC, BrowneC, KaziH, KimSF (2014) High fat diet produces brain insulin resistance, synaptodendritic abnormalities and altered behavior in mice. Neurobiol Dis67, 79–87.
19.
De FeliceFG (2013) Alzheimer’s disease and insulin resistance: Translating basic science into clinical applications. J Clin Inves123, 531–539.
20.
BalakrishnanK, VerdileG, MehtaPD, BeilbyJ, NolanD, GalvãoDA, NewtonR, GandySE, MartinsRN (2005) Plasma Abeta42 correlates positively with increased body fat in healthy individuals. J Alzheimers Dis8, 269–282.
21.
De FeliceFG, FerreiraST (2014) Inflammation, defective insulin signaling, and mitochondrial dysfunction as common molecular denominators connecting type 2 diabetes to Alzheimer disease. Diabetes63, 2262–2272.
22.
De la MonteSM, WandsJR (2008) Alzheimer’s disease is type 3 diabetes–evidence reviewed. J Diabetes Sci Technol2, 1101–1113.
TownsendM, MehtaT, SelkoeDJ (2007) Soluble Abeta inhibits specific signal transduction cascades common to the insulin receptor pathway. J Biol Chem282, 33305–33312.
25.
XieL, HelmerhorstE, TaddeiK, PlewrightB, Van BronswijkW, MartinsR (2002) Alzheimer’s β-amyloid peptides compete for insulin binding to the insulin receptor. J Neurosci22, RC221.
PuigKL, FlodenAM, AdhikariR, GolovkoMY, CombsCK (2012) Amyloid precursor protein and proinflammatory changes are regulated in brain and adipose tissue in a murine model of high fat diet-induced obesity. PLoS One7, e30378.
28.
PandiniG, PaceV, CopaniA, SquatritoS, MilardiD, VigneriR (2013) Insulin has multiple antiamyloidogenic effects on human neuronal cells. Endocrinology154, 375–387.
29.
BeydounMA, BeydounHA, WangY (2008) Obesity and central obesity as risk factors for incident dementia and its subtypes: A systematic review and meta-analysis. Obesity Rev9, 204–218.
30.
BoitardC, EtchamendyN, SauvantJ, AubertA, TronelS, MarighettoA, FerreiraG (2012) Juvenile, but not adult exposure to high-fat diet impairs relational memory and hippocampal neurogenesis in mice. Hippocampus22, 2095–2100.
31.
BruehlH, WolfOT, SweatV, TirsiA, RichardsonS, ConvitA (2009) Modifiers of cognitive function and brain structure in middle-aged and elderly individuals with type 2 diabetes mellitus. Brain Res1280, 186–194.
32.
OhH, BoghossianS, YorkD, Park-YorkM (2013) The effect of high fat diet and saturated fatty acids on insulin signaling in the amygdala and hypothalamus of rats. Brain Res1537, 191–200.
33.
PessinJE, SaltielAR (2000) Signaling pathways in insulin action: Molecular targets of insulin resistance. J Clin Inves106, 165–169.
34.
Ramos-RodriguezJJ, Ortiz-BarajasO, Gamero-CarrascoC, de la RosaPR, Infante-GarciaC, Zopeque-GarciaN, Lechuga-SanchoAM, Garcia-AllozaM (2014) Prediabetes-induced vascular alterations exacerbate central pathology in APPswe/PS1dE9 mice. Psychoneuroendocrinology48, 123–135.
35.
Ramos-RodriguezJJ, Jimenez-PalomaresM, Murillo-CarreteroMI, Infante-GarciaC, BerrocosoE, Hernandez-PachoF, Lechuga-SanchoAM, Cozar-CastellanoI, Garcia-AllozaM (2015) Central vascular disease and exacerbated pathology in a mixed model of type 2 diabetes and Alzheimer’s disease. Psychoneuroendocrinology62, 69–79.
36.
KnightEM, MartinsIV, GümüsgözS, AllanSM, LawrenceCB (2014) High-fat diet-induced memory impairment in triple-transgenic Alzheimer’s disease (3xTgAD) mice is independent of changes in amyloid and tau pathology. Neurobiol Aging35, 1821–1832.
37.
MehlaJ, ChauhanBC, ChauhanNB (2014) Experimental induction of type 2 diabetes in aging-accelerated mice triggered Alzheimer-like pathology and memory deficits. J Alzheimers Dis39, 145–162.
38.
HoL, QinW, PomplPN, XiangZ, WangJ, ZhaoZ, PengY, CambareriG, RocherA, MobbsCV, HofPR, PasinettiGM (2004) Diet-induced insulin resistance promotes amyloidosis in a transgenic mouse model of Alzheimer’s disease. FASEB J18, 902–904.
39.
JankowskyJL, FadaleDJ, AndersonJ, XuGM, GonzalesV, JenkinsNA, CopelandNG, LeeMK, YounkinLH, WagnerSL, YounkinSG, BorcheltDR (2004) Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: Evidence for augmentation of a 42-specific gamma secretase. Hum Mol Genet13, 159–170.
40.
ZhangW, BaiM, XiY, HaoJ, LiuL, MaoN, SuC, MiaoJ, LiZ (2012) Early memory deficits precede plaque deposition in APPswe/PS1dE9 mice: Involvement of oxidative stress and cholinergic dysfunction. Free Radic Biol Med52, 1443–1452.
41.
ZhangW, BaiM, XiY, HaoJ, ZhangZ, SuC, LeiG, MiaoJ, LiZ (2012) Multiple inflammatory pathways are involved in the development and progression of cognitive deficits in APPswe/PS1dE9 mice. Neurobiol Aging33, 2661–2277.
42.
ZhangW, HaoJ, LiuR, ZhangZ, LeiG, SuC, MiaoJ, LiZ (2011) Soluble Aβ levels correlate with cognitive deficits in the 12-month-old APPswe/PS1dE9 mouse model of Alzheimer’s disease. Behav Brain Res222, 342–350.
43.
PetrovD, PedrósI, ArtiachG, SuredaFX, BarrosoE, PallàsM, CasadesúsG, Beas-ZarateC, CarroE, FerrerI, Vazquez-CarreraM, FolchJ, CaminsA (2015) High-fat diet-induced deregulation of hippocampal insulin signaling and mitochondrial homeostasis deficiences contribute to Alzheimer disease pathology in rodents. Biochim Biophys Acta1852, 1687–1699.
44.
PedrósI, PetrovD, AllgaierM, SuredaF, BarrosoE, Beas-ZarateC, AuladellC, PallàsM, Vázquez-CarreraM, CasadesúsG, FolchJ, CaminsA (2014) Early alterations in energy metabolism in the hippocampus of APPswe/PS1dE9 mouse model of Alzheimer’s disease. Biochim Biophys Acta1842, 1556–1566.
45.
KurtMA, DaviesDC, KiddM, DuffK, RolphSC, JenningsKH, HowlettDR (2001) Neurodegenerative changes associated with beta-amyloid deposition in the brains of mice carrying mutant amyloid precursor protein and mutant presenilin-1 transgenes. Exp Neurol171, 59–71.
Bilkei-GorzoA (2014) Genetic mouse models of brain ageing and Alzheimer’s disease. Pharmacol Ther142, 244–257.
48.
ChomczynskiP, SacchiN (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem162, 156–159.
49.
AntunesM, BialaG (2012) The novel object recognition memory: Neurobiology, test procedure, and its modifications. Cogn Process13, 93–110.
50.
AyalaJE, SamuelVT, MortonGJ, ObiciS, CronigerCM, ShulmanGI, WassermanDH (2010) Standard operating procedures for describing and performing metabolic tests of glucose homeostasis in mice. Dis Model Mech3, 525–534.
51.
UchiyamaM, MiharaM (1978) Determination of malondialdehide precursor in tissues by thiobarbituric acid test. Anal Biochem86, 271–278.
52.
BradfordMM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem72, 248–254.
53.
Witko-SarsatV, GaussonV, NguyenAT (2003) AOPP-induced activation of human neutrophil and monocyte oxidative metabolism: A potential target for N-acetylcysteine treatment in dialysis patients. Kidney Int64, 82–91.
54.
AydinS, AtukerenP, ÇakatayU, UzunH, AltuğT (2010) Gender-dependent oxidative variations in liver of aged rats. Biogerontology11, 335–346.
55.
QinW, HaroutunianV, KatselP, CardozoCP, HoL, BuxbaumJD, PasinettiGM (2009) PGC-1alpha expression decreases in the Alzheimer disease brain as a function of dementia. Arch Neurol66, 352–361.
St-PierreJ, DroriS, UldryM, SilvaggiJM, RheeJ, JägerS, HandschinC, ZhengK, LinJ, YangW, SimonDK, BachooR, SpiegelmanBM (2006) Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators. Cell127, 397–408.
58.
AustinS, St-PierreJ (2012) PGC1α and mitochondrial metabolism–emerging concepts and relevance in ageing and neurodegenerative disorders. J Cell Sci125, 4963–4971.
59.
KamphuisW, MiddeldorpJ, KooijmanL, SluijsJA, KooiEJ, MoetonM, FreriksM, MizeeMR, HolEM (2014) Glial fibrillary acidic protein isoform expression in plaque related astrogliosis in Alzheimer’s disease. Neurobiol Aging35, 492–510.
60.
MosherKI, Wyss-CorayT (2014) Microglial dysfunction in brain aging and Alzheimer’s disease. Biochem Pharmacol88, 594–604.
61.
KnightEM, MartinsIV, GümüsgözS, AllanSM, LawrenceCB (2014) High-fat diet-induced memory impairment in triple-transgenic Alzheimer’s disease (3xTgAD) mice is independent of changes in amyloid and tau pathology. Neurobiol Aging35, 1821–1832.
62.
LeboucherA, LaurentC, Fernandez-GomezFJ, BurnoufS, TroquierL, EddarkaouiS, DemeyerD, CaillierezR, ZommerN, VallezE, BantubungiK, BretonC, PignyP, Buée-ScherrerV, StaelsB, HamdaneM, TailleuxA, BuéeL, BlumD (2013) Detrimental effects of diet-induced obesity on τ pathology are independent of insulin resistance in τ transgenic mice. Diabetes62, 1681–1688.
63.
HaqueR, NazirA (2014) Insulin-degrading enzyme: A link between Alzheimer’s and type 2 diabetes mellitus. CNS Neurol Disord Drug Targets13, 259–256.
64.
StargardtA, GillisJ, KamphuisW, WiemhoeferA, KooijmanL, RaspeM, BenckhuijsenW, DrijfhoutJW, HolEM, ReitsE (2013) Reduced amyloid-β degradation in early Alzheimer’s disease but not in the APPswePS1dE9 and 3xTg-AD mouse models. Aging Cell12, 499–507.
65.
NaveKA (2010) Myelination and the trophic support of long axons. Nat Rev Neurosci11, 275–283.
66.
YoonH, KlevenA, PaulsenA, KleppeL, WuJ, YingZ, Gomez-PinillaF, ScarisbrickIA (2016) Interplay between exercise and dietary fat modulates myelinogenesis in the central nervous system. Biochim Biophys Acta1862, 545–555.
67.
WilletteAA, BendlinBB, StarksEJ, BirdsillAC, JohnsonSC, ChristianBT, OkonkwoOC, La RueA, HermannBP, KoscikRL, JonaitisEM, SagerMA, AsthanaS (2015) Association of insulin resistance with cerebral glucose uptake in late middle-aged adults at risk for Alzheimer disease. JAMA Neurol72, 1013–1020.
68.
WilletteAA, JohnsonSC, BirdsillAC, SagerMA, ChristianB, BakerLD, CraftS, OhJ, StatzE, HermannBP, JonaitisEM, KoscikRL, La RueA, AsthanaS, BendlinBB (2015) Insulin resistance predicts brain amyloid deposition in late middle-aged adults. Alzheimers Dement11, 504–510.
TakaloM, HaapasaloA, MartiskainenH, KurkinenKM, KoivistoH, MiettinenP, KhandelwalVK, KemppainenS, KaminskaD, MäkinenP, LeinonenV, PihlajamäkiJ, SoininenH, LaaksoM, TanilaH, HiltunenM (2014) High-fat diet increases tau expression in the brain of T2DM and AD mice independently of peripheral metabolic status. J Nutr Biochem25, 634–641.
71.
Calvo-OchoaE, Hernández-OrtegaK, FerreraP, MorimotoS, AriasC (2014) Short-term high-fat-and-fructose feeding produces insulin signaling alterations accompanied by neurite and synaptic reduction and astroglial activation in the rat hippocampus. J Cereb Blood Flow Metab34, 1001–1008.
72.
KnightEM, MartinsIV, GümüsgözS, AllanSM, LawrenceCB (2014) High-fat diet-induced memory impairment in triple-transgenic Alzheimer’s disease (3xTgAD) mice is independent of changes in amyloid and tau pathology. Neurobiol Aging35, 1821–1832.
73.
LeboucherA, LaurentC, Fernandez-GomezFJ, BurnoufS, TroquierL, EddarkaouiS, DemeyerD, CaillierezR, ZommerN, VallezE, BantubungiK, BretonC, PignyP, Buée-ScherrerV, StaelsB, HamdaneM, TailleuxA, BuéeL, BlumD (2013) Detrimental effects of diet-induced obesity on τ pathology are independent of insulin resistance in τ transgenic mice. Diabetes62, 1681–1688.
74.
JhaNK, JhaSK, KumarD, KejriwalN, SharmaR, AmbastaRK, KumarP (2015) Impact of insulin degrading enzyme and neprilysin in Alzheimer’s disease biology: Characterization of putative cognates for therapeutic applications. J Alzheimers Dis48, 891–917.
75.
HaqueR, NazirA (2014) Insulin-degrading enzyme: A link between Alzheimer’s and type 2 diabetes mellitus. CNS Neurol Disord Drug Targets13, 259–264.
76.
YangY, SongW (2013) Molecular links between Alzheimer’s disease and diabetes mellitus. Neuroscience250, 140–150.
77.
EndresK, FahrenholzF (2010) Upregulation of the alpha-secretase ADAM10–risk or reason for hope?FEBS J277, 1585–1596.
78.
MusardoS, MarcelloE, GardoniF, Di LucaM (2014) ADAM10 in synaptic physiology and pathology. Neurodegener Dis13, 72–74.
79.
SaftigP, LichtenthalerSF (2015) The alpha secretase ADAM10: A metalloprotease with multiple functions in the brain. Prog Neurobiol135, 1–20.
80.
ButterfieldDA, Di DomenicoF, BaroneE (2014) Elevated risk of type 2 diabetes for development of Alzheimer disease: A key role for oxidative stress in brain. Biochim Biophys Acta1842, 1693–1706.
81.
StudzinskiCM, LiF, Bruce-KellerAJ, Fernandez-KimSO, ZhangL, WeidnerAM, MarkesberyWR, MurphyMP, KellerJN (2009) Effects of short-term Western diet on cerebral oxidative stress and diabetes related factors in APP x PS1 knock-in mice. J Neurochem108, 860–866.
WangX, ZhengW, XieJW, WangT, WangSL, TengWP, WangZY (2010) Insulin deficiency exacerbates cerebral amyloidosis and behavioral deficits in an Alzheimer transgenic mouse model. Mol Neurodegener5, 46.
84.
PengD, PanX, CuiJ, RenY, ZhangJ (2013) Hyperphosphorylation of tau protein in hippocampus of central insulin-resistant rats is associated with cognitive impairment. Cell Physiol Biochem32, 1417–1425.
85.
StranahanAM (2015) Models and mechanisms for hippocampal dysfunction in obesity and diabetes. Neuroscience309, 125–139.
86.
BesseicheA, RivelineJP, GautierJF, BréantB, BlondeauB (2015) Metabolic roles of PGC-1α and its implications for type 2 diabetes. Diabetes Metab41, 347–357.
87.
ŁukaszukB, KurekK, MikŁoszA, Żendzian-PiotrowskaM, ChabowskiA (2015) The role of PGC-1α in the development of insulin resistance in skeletal muscle - revisited. Cell Physiol Biochem37, 2288–2296.
88.
KatsouriL, ParrC, BogdanovicN, WillemM, SastreM (2011) PPARγ co-activator-1α (PGC-1α) reduces amyloid-β generation through a PPARγ-dependent mechanism. J Alzheimers Dis25, 151–162.
ChengA, WanR, YangJL, KamimuraN, SonTG, OuyangX, LuoY, OkunE, MattsonMP (2012) Involvement of PGC-1α in the formation and maintenance of neuronal dendritic spines. Nat Commun3, 1250.
91.
AshabiG, RaminM, AziziP, TaslimiZ, AlamdarySZ, HaghparastA, AnsariN, MotamediF, KhodagholiF (2012) ERK and p38 inhibitors attenuate memory deficits and increase CREB phosphorylation and PGC-1α levels in Aβ-injected rats. Behav Brain Res232, 165–173.
92.
SardariM, RezayofA, KhodagholiF (2015) Hippocampal signaling pathways are involved in stress-induced impairment of memory formation in rats. Brain Res1625, 54–63.
93.
SwerdlowRH (2012) β-Apptists and Tauists, it is time for a sermon from the book of biogenesis. J Neurochem120, 347–349.
94.
TeichAF, NichollsRE, PuzzoD, FioritoJ, PurgatorioR, Fa’M, ArancioO (2015) Synaptic therapy in Alzheimer’s disease: A CREB-centric approach. Neurotherapeutics12, 29–41.
95.
RoyA, PahanK (2015) PPARα signaling in the hippocampus: Crosstalk between fat and memory. J Neuroimmune Pharmacol10, 30–34.
96.
KidaS, SeritaT (2014) Functional roles of CREB as a positive regulator in the formation and enhancement of memory. Brain Res Bull105, 17–24.
97.
HansenRT, 3rd, ZhangHT (2013) Senescent-induced dysregulation of cAMP/CREB signaling and correlations with cognitive decline. Brain Res1516, 93–109.
98.
KandelER (2012) The molecular biology of memory: cAMP, PKA, CRE, CREB-1, CREB-2, and CPEB. Mol Brain5, 14.
